Are HIV lookbacks worthwhile? Outcome of an exercise to notify patients treated by an HIV infected health care worker. Incident Management Teams [see comments]

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Are HIV lookbacks worthwhile? Outcome of an exercise to notify patients treated by an HIV infected health care worker. Incident Management Teams [see comments]

Commun Dis Public Health. 1999 Jun;2(2):126-9. Unique Identifier : AIDSLINE MED/99331159
Donnelly M; Duckworth G; Nelson S; Wehner H; Gill N; Nazareth B; Cummins A; PHLS Communicable Disease Surveillance Centre, Thames.

Abstract: This report describes the management and outcome of one of the largest exercises undertaken in the United Kingdom to notify patients exposed to an HIV infected health care worker. Eighty-six per cent (1597/1852) of patients on whom the infected junior doctor in obstetrics and gynaecology had performed surgical procedures were contacted and 1180 women (64% of those exposed) elected to be tested. None was found to be positive. Of those tested, 651 had undergone procedures classified as 'higher risk' and 529 'low risk' procedures. These data provide further evidence that the overall risk of transmission from an infected health care worker to patients is likely to be very low. HIV lookbacks may be worthwhile but we consider that it would be justifiable to notify and offer HIV testing only to patients who have undergone higher risk procedures. The estimated cost to the NHS of this exercise exceeded 200,000 Pounds.

Keywords: JOURNAL ARTICLE Disease Notification/ECONOMICS *Disease Transmission, Professional-to-Patient Female Great Britain *Gynecology Human HIV Infections/*PREVENTION & CONTROL/*TRANSMISSION Male *Obstetrics *Outcome and Process Assessment (Health Care) Retrospective Studies Risk Factors
Comment in: Commun Dis Public Health 1999 Jun;2(2):79-81
991030
A99A0915

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .